Achieving SVR May Not Reduce Risk of HCC in Patients with HCV
“Findings from a recent study are underscoring the importance of continued surveillance for hepatocellular carcinoma (HCC) in patients with chronic hepatitis C virus (HCV), even after successful treatment with direct-acting antiviral (DAA) therapy.”
FDA fast-tracks GSK’s chronic hep B therapy bepirovirsen
“GSK’s antisense-based drug for chronic hepatitis B (CHB), bepirovirsen, will get a rapid six-month review from the FDA when it is filed for approval, said the drugmaker this morning.”
Universal Access to Hepatitis C Screening and The Role of Wastewater Testing in Predicting Outbreaks
“As public health continues to be a vital concern in the global community, the Centers for Disease Control and Prevention (CDC) has been at the forefront of developing strategies for managing infectious diseases. Two key areas of focus for the agency are the universal access to Hepatitis C screening and treatment, and the use of wastewater testing to predict disease outbreaks. Dr. Carolyn Wester from the CDC and Tim Henderson from Stateline News provide valuable insights into these critical areas of public health.”
In case you missed it:
2022 Viral Hepatitis Surveillance Status Report
“An assessment of the status of viral hepatitis surveillance practices across U.S. Jurisdictions in 2022.”
Video:
Sudbury consumption site saves health care dollars, officials argue as they await provincial funding
